Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohi, M. G.
Right arrow Articles by Watanabe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohi, M. G.
Right arrow Articles by Watanabe, S.

Vol. 9, Issue 12, 3299-3308, December 1998

Activation and Functional Analysis of Janus Kinase 2 in BA/F3 Cells Using the Coumermycin/Gyrase B System

Mohammad Golam Mohi,* Ken-ichi Arai,* and Sumiko Watanabe*Dagger

 *Department of Molecular and Developmental Biology, Institute of Medical Science, University of Tokyo, and  Dagger CREST, Japan Science and Technology Corporation, Tokyo 108-8639, Japan

Janus kinase 2 (Jak2) protein tyrosine kinase plays an important role in interleukin-3- or granulocyte-macrophage colony-stimulating factor-mediated signal transduction pathways leading to cell proliferation, activation of early response genes, and inhibition of apoptosis. However, it is unclear whether Jak2 can activate these signaling pathways directly without the involvement of cytokine receptor phosphorylation. To investigate the specific role of Jak2 in the regulation of signal transduction pathways, we generated gyrase B (GyrB)-Jak2 fusion proteins, dimerized through the addition of coumermycin. Coumermycin induced autophosphorylation of GyrB-Jak2 fusion proteins, thus bypassing receptor activation. Using different types of chimeric Jak2 molecules, we observed that although the kinase domain of Jak2 is sufficient for autophosphorylation, the N-terminal regions are essential for the phosphorylation of Stat5 and for the induction of short-term cell proliferation. Moreover, coumermycin-induced activation of Jak2 can also lead to increased levels of c-myc and CIS mRNAs in BA/F3 cells stably expressing the Jak2 fusion protein with the intact N-terminal region. Conversely, activation of the chimeric Jak2 induced neither phosphorylation of Shc or SHP-2 nor activation of the c-fos promoter. Here, we showed that the GyrB-Jak2 system can serve as an excellent model to dissect signals of receptor-dependent and -independent events. We also obtained evidence indicating a role for the N-terminal region of Jak2 in downstream signaling events.

Dagger    Corresponding author: E-mail address: sumiko{at}ims.utokyo.ac.jp.

Molecular Biology of the Cell
Vol. 9, 3299-3308, December 1998
Copyright © 1998 by The American Society for Cell Biology


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
M. Toutant, A. Costa, J.-M. Studler, G. Kadare, M. Carnaud, and J.-A. Girault
Alternative Splicing Controls the Mechanisms of FAK Autophosphorylation
Mol. Cell. Biol., November 15, 2002; 22(22): 7731 - 7743.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. G. Drachman, Y. Miyakawa, J. N. Luthi, D. D. Dahlen, A. Raney, A. E. Geddis, and K. Kaushansky
Studies with Chimeric Mpl/JAK2 Receptors Indicate That Both JAK2 and the Membrane-proximal Domain of Mpl Are Required for Cellular Proliferation
J. Biol. Chem., June 21, 2002; 277(26): 23544 - 23553.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Neff and C. A. Blau
Pharmacologically regulated cell therapy
Blood, May 1, 2001; 97(9): 2535 - 2540.
[Full Text] [PDF]

Home page
 BloodHome page
S. Watanabe, R. Zeng, Y. Aoki, T. Itoh, and K.-i. Arai
Initiation of polyoma virus origin-dependent DNA replication through STAT5 activation by human granulocyte-macrophage colony-stimulating factor
Blood, March 1, 2001; 97(5): 1266 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Lacronique, A. Boureux, R. Monni, S. Dumon, M. Mauchauffe, P. Mayeux, F. Gouilleux, R. Berger, S. Gisselbrecht, J. Ghysdael, et al.
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Blood, March 15, 2000; 95(6): 2076 - 2083.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. E. Kovanen, I. Junttila, K. Takaluoma, P. Saharinen, L. Valmu, W. Li, and O. Silvennoinen
Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells
Blood, March 1, 2000; 95(5): 1626 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. P. Sayeski, M. S. Ali, A. Safavi, M. Lyles, S.-O. Kim, S. J. Frank, and K. E. Bernstein
A Catalytically Active Jak2 Is Required for the Angiotensin II-dependent Activation of Fyn
J. Biol. Chem., November 12, 1999; 274(46): 33131 - 33142.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. P. Sayeski, M. S. Ali, K. Hawks, S. J. Frank, and K. E. Bernstein
The Angiotensin II–Dependent Association of Jak2 and c-Src Requires the N-Terminus of Jak2 and the SH2 Domain of c-Src
Circ. Res., June 11, 1999; 84(11): 1332 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-B. Liu, T. Itoh, K.-i. Arai, and S. Watanabe
Constitutive Activation of JAK2 Confers Murine Interleukin-3-independent Survival and Proliferation of BA/F3 Cells
J. Biol. Chem., March 5, 1999; 274(10): 6342 - 6349.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kamizono, T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Hattori, S. Hatakeyama, M. Yada, S. Morita, et al.
The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2
J. Biol. Chem., April 13, 2001; 276(16): 12530 - 12538.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]